ScandiDos has received a combined order totaling 478 000 EUR for multiple Delta4 Phantom+ measurement systems. This significant deal results from collaboration with the reputable distributor, Beijing HGPT Technology & Trade Co. Ltd, and concerns several prominent hospitals in China. Anticipated deliveries of the measurement systems are scheduled during the current quarter.

ScandiDos has seen considerable demand for its products in China in the past year. The growing business is attributed to the increasing need for advanced radiotherapy treatment technologies to handle the booming cancer patient population. Delta4 Phantom+ has become the preferred choice for more than 100 hospitals in China.

“In 2023, Asia has proven to be the market where we've achieved our greatest success, and the Chinese market is no exception. The notable demand for ScandiDos' patient QA solutions in China is a testament to our successful establishment as a reliable partner. Our innovative products effectively meet the demands for workflow and efficiency set by Chinese hospitals and clinics," says Gustaf Piehl, CEO of ScandiDos."

© Modular Finance, source Nordic Press Releases